Dukagjin M Blakaj

Dukagjin M Blakaj

Ohio State University - Columbus / United States
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 885123
person_outline Dukagjin M Blakaj's MOST POPULAR ARTICLES
1-) Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial The Lancet 393 (10166), 40-50, 2019
2-) Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002) Journal of Clinical Oncology 39 (9), 956-965, 2021
3-) Phase IIb, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer Journal of Clinical Oncology 37 (34), 3256-3265, 2019
4-) Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data Oral oncology 95, 29-34, 2019
5-) NRG-HN002: a randomized phase II trial for patients with p16-positive, non-smoking-associated, locoregionally advanced oropharyngeal cancer International Journal of Radiation Oncology, Biology, Physics 105 (3), 684-685, 2019